Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	754	676	1,350	1,900	1,391	610
Market Cap Growth	-59.71%	-49.94%	-28.99%	36.58%	128.10%	-34.65%
Enterprise Value	709	513	1,307	1,610	1,274	416
PE Ratio	-	-6.06	-4.85	-10.55	-8.21	-4.17
PS Ratio	4.07	4.65	12.33	14.42	7.02	3.48
PB Ratio	10.07	3.36	31.49	6.29	6.59	2.76
P/FCF Ratio	-1.73	-2.10	-6.28	-48.80	-20.67	-8.27
P/OCF Ratio	-1.85	-2.41	-7.24	-128.48	-32.55	-10.48
EV/Sales Ratio	3.87	3.54	11.94	12.21	6.42	2.37
EV/EBITDA Ratio	-4.97	-8.38	-5.30	-10.93	-8.78	-3.88
EV/EBIT Ratio	-3.68	-5.14	-4.89	-10.06	-7.50	-3.26
EV/FCF Ratio	-1.62	-1.59	-6.08	-41.33	-18.93	-5.64
Debt / Equity Ratio	5.45	2.02	9.51	0.87	1.16	0.93
Debt / EBITDA Ratio	-3.65	-6.60	-1.65	-1.78	-1.68	-1.91
Debt / FCF Ratio	-1.19	-1.26	-1.90	-6.73	-3.63	-2.78
Quick Ratio	2.68	3.31	3.28	4.58	4.07	4.36
Current Ratio	2.78	3.47	3.42	4.70	4.43	4.50
Asset Turnover	0.24	0.18	0.15	0.17	0.31	0.28
Interest Coverage	-13.16	-8.81	-24.26	-8.13	-8.91	-6.78
Return on Equity (ROE)	-96.00%	-56.70%	-219.10%	-55.20%	-64.10%	-56.90%
Return on Assets (ROA)	-21.30%	-14.10%	-37.00%	-23.50%	-26.60%	-23.10%
Return on Capital (ROIC)	-86.13%	-64.09%	-71.02%	-35.35%	-37.89%	-25.19%
Earnings Yield	-21.60%	-16.49%	-20.63%	-9.48%	-12.18%	-24.00%
FCF Yield	-45.39%	-47.71%	-15.92%	-2.05%	-4.84%	-12.09%
Buyback Yield / Dilution	-13.15%	-16.48%	-6.56%	-25.86%	-12.28%	-4.72%
Total Shareholder Return	-13.15%	-16.48%	-6.56%	-25.86%	-12.28%	-4.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).